Journal of Enzyme Inhibition and Medicinal Chemistry (Jan 2020)

Novel sulphonamides incorporating triazene moieties show powerful carbonic anhydrase I and II inhibitory properties

  • Sinan Bilginer,
  • Baris Gonder,
  • Halise Inci Gul,
  • Ruya Kaya,
  • Ilhami Gulcin,
  • Baris Anil,
  • Claudiu T. Supuran

DOI
https://doi.org/10.1080/14756366.2019.1700240
Journal volume & issue
Vol. 35, no. 1
pp. 325 – 329

Abstract

Read online

A series of compounds incorporating 3-(3-(2/3/4-substituted phenyl)triaz-1-en-1-yl) benzenesulfonamide moieties were synthesised and their chemical structure was confirmed by physico-chemical methods. Carbonic anhydrase (CA, EC 4.2.1.1) inhibitory effects of the compounds were evaluated against human isoforms hCA I and II. KI values of these sulphonamides were in the range of 21 ± 4–72 ± 2 nM towards hCA I and in the range of 16 ± 6–40 ± 2 nM against hCA II. The 4-fluoro substituted derivative might be considered as an interesting lead due to its effective inhibitory action against both hCA I and hCA II (KIs of 21 nM), a profile rarely seen among other sulphonamide CA inhibitors, making it of interest in systems where the activity of the two cytosolic isoforms is dysregulated.

Keywords